Clinical trial
Study To Evaluate The Safety, Pharmacokinetics, And Pharmacodynamics Of…
NCT00225121 · Pfizer, Industry · Completed
Key facts
| NCT number | NCT00225121 |
|---|---|
| Title | Study To Evaluate The Safety, Pharmacokinetics, And Pharmacodynamics Of PF-00299804 In Patients With Advanced Solid Tumors |
| Official title | A PHASE 1, OPEN-LABEL, DOSE-ESCALATION STUDY TO EVALUATE SAFETY, PHARMACOKINETICS AND PHARMACODYNAMICS OF 2 DOSING SCHEDULES OF PF-00299804 IN PATIENTS WITH ADVANCED MALIGNANT SOLID TUMORS |
| Lead sponsor | Pfizer, Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Neoplasms |
| Intervention type | Drug |
| Interventions | PF-00299804 |
| Enrollment | 121 |
| Start date | Oct 11, 2005 |
| Primary completion | Apr 3, 2007 |
| Completion | Sep 23, 2010 |
| First posted | Sep 23, 2005 |
| Last update posted | Dec 21, 2018 |
| Countries | Netherlands, United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: